Bayer AG
XETRA:BAYN
Bayer AG
XETRA:BAYN
Price:
26.895 EUR
-0.28%
Market Closed
Updated:
Apr 25, 2024
Bayer AG
Income from Continuing Operations
|
Bayer AG
Income from Continuing Operations Peer Comparison
Comparables:
ATAI
MRK
93M1
DMP
PSG
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bayer AG
XETRA:BAYN
|
Income from Continuing Operations
-€2.9B
|
CAGR 3-Years
43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Income from Continuing Operations
-$40.3m
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck KGaA
XETRA:MRK
|
Income from Continuing Operations
€2.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Income from Continuing Operations
€29.1m
|
CAGR 3-Years
38%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Income from Continuing Operations
€60.5m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Income from Continuing Operations
€12m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Income from Continuing Operations?
Income from Continuing Operations
-2.9B
EUR
-2.9B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Income from Continuing Operations amounts to -2.9B EUR.
What is Bayer AG's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
43%
43%
The average annual Income from Continuing Operations growth rates for Bayer AG have been 43% over the past three years .
You don't have any saved screeners yet
